Aurobindo Pharma Limited

Form 483

Sangareddy, -, IndiaFEI 3004021263Issued September 21, 2012

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3004021263.

Observations7

Issue DateSeptember 21, 2012

Status1 Related Warning Letter

Related Inspections5

Establishment Details

Firm: Aurobindo Pharma Limited
Location: Sangareddy, -, India
FEI Number: 3004021263
Product Type: Drugs
Issue Date: September 21, 2012
Country: India

Inspection History, 2010 to 2023

NAI1

VAI3

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Aurobindo Pharma Limited FDA Form 483, Sangareddy, September 21, 2012